Generic selection criteria for safety and patient benefit [XII] : Comparing the physicochemical and pharmaceutical properties of brand-name and generic tulobuterol tape

被引:0
|
作者
Shimokawa, Ken-ichi [1 ]
Yotsukura, Kayo [1 ]
Nozawa, Mitsuru [2 ]
Wada, Yuko [3 ]
Ishii, Fumiyoshi [3 ]
机构
[1] Meiji Pharmaceut Univ, Dept Pharmaceut Sci, 2-522-1 Noshio, Kiyose, Tokyo 2048588, Japan
[2] Triad Japan Co Ltd, Sagamihara, Kanagawa, Japan
[3] Meiji Pharmaceut Univ, Dept Selfmedicat & Hlth Care Sci, Tokyo, Japan
关键词
Transdermal therapeutic drug; brand-name drug; generic drug; tulobuterol tape; USABILITY;
D O I
10.5582/ddt.2023.01076
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Physicochemical properties (drug release, peel strength, adhesion, and stiffness) of Hokunalin((R)) Tape (Hokunalin) and 13 generic transdermal bronchodilator patches containing tulobuterol were characterized and evaluated for comparison. Drug-release studies evaluating sustained release behavior demonstrated better performance by the drug Hokunalin, than the generics MED, YP, Sawai, and Teikoku. Hokunalin yield a 16.2% release 1 hour after initiation, 30.1% at 3 hours, 50.0% at 8 hours. In comparison, the generics MED, YP, Sawai, and Teikoku showed an intermediate release behavior to that of Hokunalin, with more than 80% release after 8 hours. A 90-degree peel adhesion test for tape peel strength demonstrated that the generic MED (4.99 N), YP (3.26 N), Sawai (4.17 N), and Teikoku (4.37 N) tapes yielded significantly higher values compared to Hokunalin (2.66 N). Probe tack tests, evaluating adhesive strength, yielded significantly higher values for the generics HMT (4.89 N) and Towa (4.25 N) compared to Hokunalin (3.66 N). Furthermore, for the stiffness-softness test, a significantly higher value was obtained for each generic yielded compared to Hokunalin (3.7-degree). These factors are important components of product qualities that affect treatment efficacy, including "ease of application" and other usability factors.
引用
收藏
页数:6
相关论文
共 45 条
  • [1] Generic selection criteria for safety and patient benefit [VI]: Comparing the physicochemical and pharmaceutical properties of brand-name, generic, and OTC felbinac tapes
    Wada, Yuko
    Takaoka, Yukie
    Nozawa, Mitsuru
    Goto, Miho
    Shimokawa, Ken-ichi
    Ishii, Fumiyoshi
    [J]. Drug Discoveries and Therapeutics, 2016, 10 (06): : 300 - 306
  • [2] Generic selection criteria for safety and patient benefit [VIII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic diclofenac sodium tapes
    Nozawa, Mitsuru
    Goto, Miho
    Wada, Yuko
    Yotsukura, Kayo
    Gannichida, Ako
    Ishii, Fumiyoshi
    Shimokawa, Ken-ichi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2019, 13 (03): : 150 - 156
  • [3] Generic selection criteria for safety and patient benefit [VII]: Comparing the physicochemical and pharmaceutical properties of brand-name and generic terbinafine hydrochloride cream
    Nozawa, Mitsuru
    Goto, Miho
    Wada, Yuko
    Kumazawa, Miyuki
    Shimokawa, Ken-ichi
    Ishii, Fumiyoshi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2018, 12 (01): : 16 - 20
  • [4] Generic Selection Criteria for Safety and Patient Benefit [IV] Physicochemical and pharmaceutical properties of brand-name and generic ketoprofen tapes
    Wada, Yuko
    Kihara, Maki
    Nozawa, Mitsuru
    Shimokawa, Ken-ichi
    Ishii, Fumiyoshi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2015, 9 (03): : 229 - 233
  • [5] Generic selection criteria for safety and patient benefit [X]: Water-vapor permeability and peel force properties of brand-name and generic ketoprofen tapes
    Nozawa, Mitsuru
    Goto, Miho
    Wada, Yuko
    Ishii, Fumiyoshi
    Shimokawa, Ken-ichi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2021, 15 (02): : 87 - 92
  • [6] Generic selection criteria for safety and patient benefit [V]: Comparing the pharmaceutical properties and patient usability of original and generic nasal spray containing ketotifen fumarate
    Wada, Yuko
    Ami, Shyoko
    Nozawa, Mitsuru
    Goto, Miho
    Shimokawa, Ken-ichi
    Ishii, Fumiyoshi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2016, 10 (02): : 88 - 92
  • [7] GENERIC AND ALTERNATIVE BRAND-NAME PHARMACEUTICAL EQUIVALENTS - SELECT WITH CAUTION
    HENDELES, L
    HOCHHAUS, G
    KAZEROUNIAN, S
    [J]. AMERICAN JOURNAL OF HOSPITAL PHARMACY, 1993, 50 (02): : 323 - 329
  • [8] Comparison of the Properties of Brand-Name and Generic Nadifloxacin Creams
    Inoue, Yutaka
    Matsumoto, Miruto
    Kimura, Masayuki
    Tanaka, Toru
    Kanamoto, Ikuo
    [J]. MEDICINA-LITHUANIA, 2011, 47 (11): : 616 - 622
  • [9] Generic selection criteria for safety and patient benefit [XI]: Usability scores of brand- name and generic tapes containing sodium diclofenac by questionnaire survey
    Nozawa, Mitsuru
    Gannichida, Ako
    Wada, Yuko
    Kumazawa, Miyuki
    Ishii, Fumiyoshi
    Shimokawa, Ken-ichi
    [J]. DRUG DISCOVERIES AND THERAPEUTICS, 2022, 16 (05): : 210 - 216
  • [10] Safety of Overnight Switch from Brand-Name to Generic Levetiracetam
    Vari, Maria Stella
    Pinto, Francesca
    Mencaroni, Elisabetta
    Giudizioso, Giovanna
    Minetti, Carlo
    La Neve, Angela
    Francavilla, Tiziana
    Piccioli, Marta
    Striano, Salvatore
    del Gaudio, Luigi
    Tovo, Pierangelo
    Striano, Pasquale
    Verrotti, Alberto
    [J]. CLINICAL DRUG INVESTIGATION, 2016, 36 (01) : 87 - 91